57896-454 : Geri-kot 8.6 mg Oral Tablet


NDC: 57896-454
Labeler: Geri-care Pharmaceutical Corp
Product Type: Human OTC Drug
Drug Name: Geri-kot
Dosage Form: Oral Tablet
Application #: part334
Rev. Date: 


Appearance:


Markings: AZ217
Shapes:  Round
Colors:  Brown
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 57896-454-01: 100 TABLET IN 1 BOTTLE (57896‑454‑01)
  • 57896-454-10: 1000 TABLET IN 1 BOTTLE (57896‑454‑10)
  • 57896-454-20: 200 TABLET IN 1 BOTTLE (57896‑454‑20)

Active Ingredients:

  • Sennosides

Dosage Strength:

  • 8.6 mg

Inactive Ingredients:

  • Carnauba Wax
  • Silicon Dioxide
  • Cellulose, Microcrystalline
  • Croscarmellose Sodium
  • Calcium Phosphate, Dibasic, Anhydrous
  • Magnesium Silicate
  • Magnesium Stearate
  • Mineral Oil
  • Polyethylene Glycol, Unspecified
  • Hypromelloses /

Related Products:

Based on records with the same trade name.
  • 57896-415 Geri-kot 8.6 mg Oral Tablet by Geri-care Pharmaceutical Corp
  • 57896-417 Geri-kot 8.6 mg Oral Tablet by Geri-care Pharmaceutical Corp
  • 57896-450 Geri-kot 8.6 mg Oral Tablet by Geri-care Pharmaceutical Corp
  • 57896-451 Sennosides, Usp 8.6 mg Oral Tablet by Geri-care Pharmaceutical Corp
  • 53808-1110 Geri-kot 8.6 mg Oral Tablet by Doh Central Pharmacy
  • 71335-1806 Geri-kot 8.6 mg Oral Tablet by Bryant Ranch Prepack
  • 71335-2230 Geri-kot 8.6 mg Oral Tablet by Bryant Ranch Prepack

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 57896-454 QR Code

< Prev: 57896-452Next: 57896-455 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.